Product Details
Arimistane is a synthetic compound classified as an aromatase-interacting agent and is structurally related to metabolites derived from 7-keto DHEA. It is utilized in controlled research environments for the study of enzymatic activity associated with steroidogenesis pathways.
Within laboratory settings, arimistane is examined for its interaction with enzymes involved in hormone biosynthesis. Its molecular structure supports investigation into enzyme-binding dynamics and pathway modulation at the biochemical level.
This compound is supplied strictly for laboratory research purposes and is not intended for consumption, medical, or diagnostic use.
Mechanism of Action
At the molecular level, arimistane is studied for its interaction with the aromatase enzyme, a cytochrome P450-associated protein responsible for catalyzing the conversion of androgenic substrates into estrogenic compounds.
Arimistane is characterized by its ability to bind to the active site of the aromatase enzyme, where it may form a stable interaction that alters enzymatic activity. This interaction is examined in vitro to evaluate how substrate conversion processes are affected within steroidogenic pathways.
Additionally, research focuses on how arimistane influences enzyme structure and catalytic function, including its interaction with the heme moiety located at the active site. These studies contribute to a broader understanding of enzyme inhibition mechanisms and pathway regulation under controlled experimental conditions.
Chemical Properties of Arimistane
| Attribute | Details |
| Compound Name | Arimistane |
| Classification | Aromatase-interacting compound |
| Molecular Formula | C19H22O2 |
| Molecular Weight | 284.4 g/mol |
| CAS Number | 1420-49-1 |
| IUPAC Name | (8R,9S,10R,13S,14S)-10,13-dimethyl-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthrene-7,17-dione |
| Synonyms | Androsta-3,5-diene-7,17-dione; NSC 134910 |
| Primary Target | Aromatase enzyme (CYP19A1) |
| Research Context | Enzyme inhibition and steroidogenesis pathway analysis |
| Format | Research compound (non-consumable) |
| Stability | Stable under controlled laboratory storage conditions |
Research Applications
Enzyme Inhibition Studies
Arimistane is utilized in experimental systems to analyze interactions with the aromatase enzyme. Researchers evaluate binding affinity, catalytic modulation, and enzyme-ligand dynamics.
Steroidogenesis Pathway Analysis
This compound is applied in studies investigating biochemical pathways involved in steroid synthesis. These analyses focus on enzymatic conversion processes and pathway regulation at the molecular level.
Molecular Interaction Research
Arimistane supports investigations into enzyme structure and active-site interactions, including studies on heme-associated binding mechanisms and conformational changes.
Why Choose BehemothLabz to Buy Arimistane for Research
BehemothLabz provides research-grade Arimistane manufactured under controlled laboratory conditions with strict quality assurance protocols. Each batch undergoes analytical verification to ensure consistency in molecular composition and purity.
Comprehensive documentation, including laboratory testing reports and sourcing transparency, supports reproducibility in experimental settings. BehemothLabz maintains a compliance-focused approach, supplying compounds intended strictly for laboratory-based investigation and analytical research
Disclaimer
Arimistane is intended strictly for laboratory research and analytical purposes only. It is not intended for use in diagnostic procedures, therapeutic applications, or in vivo studies of any kind.
Any references to biochemical pathways, receptor interactions, or enzymatic processes are provided solely for informational and research-context purposes. This compound must be handled exclusively by qualified professionals in controlled laboratory environments in accordance with applicable regulations and safety guidelines.
Improper handling or use outside of controlled research settings is strictly prohibited.
References
- Martinez Brito, D., Leogrande, P., Botrè, F., & de la Torre, X. (2021). Detection of urinary arimistane metabolites in humans using liquid chromatography-mass spectrometry: Complementary results to gas chromatography mass spectrometric data and its application to antidoping analyses. Rapid communications in mass spectrometry : RCM, 35(12), e9080. https://doi.org/10.1002/rcm.9080
- Martinez Brito, D., de la Torre, X., & Botrè, F. (2019). Detection of urinary metabolites of arimistane in humans by gas chromatography coupled to high-accuracy mass spectrometry for antidoping analyses. Rapid communications in mass spectrometry : RCM, 33(24), 1894–1905. https://doi.org/10.1002/rcm.8529
